Barclays’s CorMedix CRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.79M Buy
145,525
+57,734
+66% +$711K ﹤0.01% 2307
2025
Q1
$541K Sell
87,791
-17,811
-17% -$110K ﹤0.01% 2798
2024
Q4
$855K Buy
105,602
+27,732
+36% +$225K ﹤0.01% 2722
2024
Q3
$629K Sell
77,870
-84,122
-52% -$680K ﹤0.01% 2861
2024
Q2
$702K Sell
161,992
-19,756
-11% -$85.6K ﹤0.01% 2316
2024
Q1
$771K Sell
181,748
-36,898
-17% -$157K ﹤0.01% 2582
2023
Q4
$822K Buy
218,646
+66,318
+44% +$249K ﹤0.01% 2740
2023
Q3
$564K Buy
152,328
+282
+0.2% +$1.04K ﹤0.01% 2468
2023
Q2
$603K Sell
152,046
-11,477
-7% -$45.5K ﹤0.01% 2480
2023
Q1
$677K Buy
163,523
+20,391
+14% +$84.4K ﹤0.01% 2423
2022
Q4
$604K Hold
143,132
﹤0.01% 2476
2022
Q3
$405K Sell
143,132
-606,868
-81% -$1.72M ﹤0.01% 2708
2022
Q2
$3.02M Buy
750,000
+743,846
+12,087% +$2.99M ﹤0.01% 1342
2022
Q1
$34K Sell
6,154
-39,842
-87% -$220K ﹤0.01% 4143
2021
Q4
$209K Buy
45,996
+30,509
+197% +$139K ﹤0.01% 2816
2021
Q3
$72K Sell
15,487
-3,688
-19% -$17.1K ﹤0.01% 3312
2021
Q2
$131K Sell
19,175
-8,048
-30% -$55K ﹤0.01% 3048
2021
Q1
$272K Buy
27,223
+16,978
+166% +$170K ﹤0.01% 2991
2020
Q4
$76K Sell
10,245
-3,663
-26% -$27.2K ﹤0.01% 3054
2020
Q3
$84K Sell
13,908
-275
-2% -$1.66K ﹤0.01% 3089
2020
Q2
$89K Buy
14,183
+5,717
+68% +$35.9K ﹤0.01% 3169
2020
Q1
$30K Sell
8,466
-16,925
-67% -$60K ﹤0.01% 3270
2019
Q4
$185K Buy
25,391
+13,501
+114% +$98.4K ﹤0.01% 3213
2019
Q3
$75K Sell
11,890
-4,141
-26% -$26.1K ﹤0.01% 3539
2019
Q2
$143K Sell
16,031
-15,967
-50% -$142K ﹤0.01% 3387
2019
Q1
$302K Buy
+31,998
New +$302K ﹤0.01% 2849
2018
Q2
Sell
-11
Closed 4213
2018
Q1
$0 Buy
+11
New ﹤0.01% 4218
2016
Q3
Sell
-731
Closed -$7K 3942
2016
Q2
$7K Buy
+731
New +$7K ﹤0.01% 3060
2015
Q4
Sell
-36
Closed 3286
2015
Q3
$0 Sell
36
-83
-70% ﹤0.01% 3968
2015
Q2
$2K Buy
+119
New +$2K ﹤0.01% 3897